DataMeds AI (MEDS) Total Liabilities (2023 - 2026)

DataMeds AI (MEDS) has reported Total Liabilities for 4 consecutive years, with $45.2 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 15.67% year-over-year to $45.2 million; the trailing twelve-month figure through Mar 2026 stood at $45.2 million (down 15.67% YoY), and the FY2025 full-year result was $42.9 million, down 15.2% from the prior year.
• Total Liabilities grew to $45.2 million in Q1 2026 per MEDS's latest filing, from $42.9 million in the prior quarter.
• Across five years, Total Liabilities topped out at $53.6 million in Q1 2025 and bottomed at -$10.0 million in Q3 2024.
• Historically, Total Liabilities has averaged $29.1 million across 4 years, with a median of $44.0 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Total Liabilities jumped 1695.99% in 2025, then fell 15.67% in 2026.
• Over 4 years, Total Liabilities stood at $3.2 million in 2023, then jumped by 1462.25% to $50.6 million in 2024, then fell by 15.2% to $42.9 million in 2025, then grew by 5.32% to $45.2 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $45.2 million, $42.9 million, and $46.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.